News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
73,000 Results
Type
Article (1323)
Company Profile (8)
Press Release (71669)
Section
Business (35053)
Career Advice (41)
Deals (5428)
Drug Delivery (2)
Drug Development (7937)
Employer Resources (4)
FDA (1291)
Job Trends (1871)
News (47340)
Policy (2202)
Tag
Academia (103)
Accelerated approval (1)
Adcomms (2)
Allergies (8)
Alliances (2208)
ALS (6)
Alzheimer's disease (92)
Antibody-drug conjugate (ADC) (10)
Approvals (1312)
Artificial intelligence (14)
Autoimmune disease (2)
Bankruptcy (17)
Best Places to Work (1805)
Biosimilars (15)
Biotechnology (5)
Bladder cancer (20)
Brain cancer (2)
Breast cancer (52)
Cancer (288)
Cardiovascular disease (15)
Career advice (37)
CAR-T (8)
Cell therapy (31)
Cervical cancer (3)
Clinical research (7144)
Collaboration (44)
Compensation (24)
Complete response letters (1)
COVID-19 (129)
CRISPR (4)
C-suite (5)
Cystic fibrosis (9)
Data (347)
Depression (5)
Diabetes (32)
Diagnostics (734)
Digital health (1)
Diversity, equity & inclusion (2)
Drug discovery (6)
Drug pricing (5)
Duchenne muscular dystrophy (18)
Earnings (32121)
Employer resources (4)
Events (11388)
Executive appointments (19)
FDA (1495)
Frontotemporal dementia (1)
Funding (27)
Gene editing (8)
Generative AI (2)
Gene therapy (18)
GLP-1 (63)
Government (212)
Guidances (100)
Healthcare (2200)
IgA nephropathy (1)
Immunology and inflammation (10)
Indications (3)
Infectious disease (142)
Inflammatory bowel disease (8)
Influenza (7)
Intellectual property (9)
Interviews (2)
IPO (4182)
Job creations (156)
Job search strategy (36)
Kidney cancer (3)
Labor market (2)
Layoffs (23)
Legal (342)
Liver cancer (2)
Lung cancer (47)
Lymphoma (38)
Manufacturing (14)
MASH (20)
Medical device (1909)
Medtech (1909)
Mergers & acquisitions (1299)
Metabolic disorders (82)
Multiple sclerosis (17)
NASH (7)
Neurodegenerative disease (2)
Neuropsychiatric disorders (2)
Neuroscience (151)
NextGen: Class of 2025 (565)
Non-profit (371)
Obesity (38)
Opinion (4)
Ovarian cancer (10)
Pain (6)
Pancreatic cancer (11)
Parkinson's disease (20)
Patents (20)
Patient recruitment (3)
Peanut (4)
People (1914)
Pharmaceutical (3)
Pharmacy benefit managers (3)
Phase I (1750)
Phase II (2940)
Phase III (2964)
Pipeline (514)
Postmarket research (269)
Preclinical (469)
Prostate cancer (7)
Psychedelics (1)
Radiopharmaceuticals (28)
Rare diseases (31)
Real estate (182)
Recruiting (2)
Regulatory (1806)
Reports (7)
Research institute (129)
Resumes & cover letters (3)
RSV (7)
Schizophrenia (10)
Series A (2)
Series B (2)
Service/supplier (1)
Sickle cell disease (6)
Special edition (3)
Spinal muscular atrophy (23)
Sponsored (2)
Startups (104)
Stomach cancer (1)
Supply chain (1)
Tariffs (1)
Vaccines (37)
Weight loss (15)
Women's health (1)
Date
Last 7 days (246)
Last 30 days (528)
Last 365 days (4894)
2025 (1758)
2024 (5659)
2023 (6569)
2022 (7277)
2021 (8036)
2020 (6939)
2019 (4882)
2018 (3853)
2017 (3293)
2016 (2417)
2015 (3551)
2014 (2458)
2013 (1585)
2012 (1828)
2011 (2133)
2010 (1818)
Location
Africa (32)
Alabama (7)
Arizona (17)
Asia (4235)
Australia (359)
California (911)
Canada (259)
China (44)
Colorado (52)
Connecticut (39)
Delaware (36)
Europe (8963)
Florida (179)
Georgia (32)
Idaho (4)
Illinois (52)
India (2)
Indiana (57)
Japan (13)
Kansas (8)
Kentucky (2)
Louisiana (3)
Maine (13)
Maryland (118)
Massachusetts (779)
Michigan (38)
Minnesota (55)
Missouri (11)
Montana (3)
Nevada (10)
New Hampshire (9)
New Jersey (322)
New Mexico (2)
New York (310)
North Carolina (192)
Northern California (443)
Ohio (18)
Oregon (2)
Pennsylvania (231)
Rhode Island (2)
South America (70)
South Carolina (2)
Southern California (344)
Tennessee (12)
Texas (165)
United States (3761)
Utah (42)
Virginia (9)
Washington D.C. (11)
Washington State (84)
Wisconsin (10)
73,000 Results for "83".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Intravenous Immunoglobulin Market Size to Hit USD 28.83 Billion by 2034
February 14, 2025
·
1 min read
Press Releases
Arcutis to Present Two Posters at the 83rd American Academy of Dermatology Annual Meeting
February 28, 2025
·
7 min read
Press Releases
U.S. Biopharmaceuticals Contract Manufacturing Market Size to Hit USD 7.83 Billion by 2033
February 26, 2025
·
1 min read
Press Releases
Linnaeus Therapeutics Awarded Its Fourth Competitive SBIR Award by the National Cancer Institute Bringing Total SBIR Funding to $8.3 Million
March 27, 2025
·
2 min read
Press Releases
U.S. Pharmaceutical CDMO Market Size to Surpass 83.25 Bn by 2034
January 20, 2025
·
1 min read
Press Releases
Mallia Therapeutics and Northway Biotech Announce Partnership for the Manufacturing of Soluble CD83 Protein for Hair Loss Treatment
February 4, 2025
·
3 min read
Press Releases
Arcutis to Highlight Data from Phase 3 Trials for Scalp and Body Psoriasis and Atopic Dermatitis at the 83rd American Academy of Dermatology Meeting
March 10, 2025
·
8 min read
Press Releases
U.S. Pharmaceutical CDMO Market to Reach USD 83.86 Billion to 2034
December 23, 2024
·
1 min read
Press Releases
Pancreatic Ductal Carcinoma Markets Expected to Grow at a CAGR Of 5.83% During 2025-2035, impelled by Advancements in Innovative Therapies.
February 5, 2025
·
6 min read
Press Releases
Phio Pharmaceuticals Announces $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 16, 2025
·
6 min read
1 of 7,300
Next
